Check out Pro
Top Companies
Recent Trades
Cluster Buys
Sectors
Blog
Join the Insiderviz Pro waitlist
Carisma Therapeutics Inc. (CARM)
All trades on this company by insiders. Hover over bubbles for specific trade details. Drag along the graph for custom price change. Green - Buy, Red - Sell, Orange - Congress Member.
Healthcare
Biotechnology
DATE
INSIDER
COMPANY
OWNED SHARES
SHARES TRADED
PRICE
NET TOTAL
SELL
2 Mar 2023
Forbes Monica
Chief Financial Officer, Officer
Sesen Bio, Inc.
(SESN)
326,122
-51%
345,849
$0.59
$203,013.36
SELL
2 Mar 2023
MacDonald Glen C
Chief Technology Officer, Officer
Sesen Bio, Inc.
(SESN)
206,751
-45%
170,372
$0.59
$100,008.37
SELL
2 Mar 2023
Ryu Elly
Principal Accounting Officer, Officer
Sesen Bio, Inc.
(SESN)
148,624
-10%
17,289
$0.59
$10,148.64
SELL
2 Mar 2023
Cannell Thomas R
President and CEO, Director, Officer
Sesen Bio, Inc.
(SESN)
344,150
-58%
487,487
$0.59
$286,154.88
SELL
2 Mar 2023
Sullivan Mark
General Counsel & Secretary, Officer
Sesen Bio, Inc.
(SESN)
198,716
-52%
219,218
$0.59
$128,680.97
SELL
21 Feb 2023
MacDonald Glen C
Chief Technology Officer, Officer
Sesen Bio, Inc.
(SESN)
282,998
-8%
25,927
$0.59
$15,226.93
SELL
21 Feb 2023
Forbes Monica
Chief Financial Officer, Officer
Sesen Bio, Inc.
(SESN)
480,388
-11%
61,862
$0.59
$36,331.56
SELL
21 Feb 2023
Ryu Elly
Principal Accounting Officer, Officer
Sesen Bio, Inc.
(SESN)
165,913
-4%
7,159
$0.59
$4,204.48
SELL
21 Feb 2023
Cannell Thomas R
President and CEO, Director, Officer
Sesen Bio, Inc.
(SESN)
553,073
-8%
53,727
$0.59
$31,553.87
SELL
21 Feb 2023
Sullivan Mark
General Counsel & Secretary, Officer
Sesen Bio, Inc.
(SESN)
299,694
-11%
39,831
$0.59
$23,392.75
SELL
14 Feb 2017
MCCABE JOHN J
Chief Financial Officer, Officer
Eleven Biotherapeutics, Inc.
(EBIO)
5,930
-19%
1,399
$2.10
$2,937.90
SELL
28 Sep 2016
Celniker Abbie
Director
Eleven Biotherapeutics, Inc.
(EBIO)
409,915
-2%
10,031
$3.00
$30,093.00
SELL
22 Sep 2016
Flagship Ventures Fund IV, L.P.
10% Owner
Eleven Biotherapeutics, Inc.
(EBIO)
468,063
-48%
443,422
$3.16
$1,403,297.60
SELL
19 Sep 2016
Flagship Ventures Fund IV, L.P.
10% Owner
Eleven Biotherapeutics, Inc.
(EBIO)
781,643
-33%
386,340
$3.69
$1,425,096.90
SELL
14 Sep 2016
Flagship Ventures Fund IV, L.P.
10% Owner
Eleven Biotherapeutics, Inc.
(EBIO)
1,090,757
-4%
46,692
$4.18
$195,118.94
SELL
6 Sep 2016
Flagship Ventures Fund IV, L.P.
10% Owner
Eleven Biotherapeutics, Inc.
(EBIO)
1,833,802
-6%
129,497
$4.54
$588,323.90
SELL
15 Aug 2016
MCCABE JOHN J
Chief Financial Officer, Officer
Eleven Biotherapeutics, Inc.
(EBIO)
7,329
-13%
1,170
$4.80
$5,616.00
SELL
27 Jun 2016
Tubridy Karen L
Chief Development Officer, Officer
Eleven Biotherapeutics, Inc.
(EBIO)
32,753
-11%
4,372
$2.08
$9,093.76
SELL
27 Jun 2016
Celniker Abbie
President and CEO, Director, Officer
Eleven Biotherapeutics, Inc.
(EBIO)
419,946
-2%
10,029
$2.08
$20,860.32
SELL
13 Jun 2016
Boxer Capital, LLC
10% Owner
Eleven Biotherapeutics, Inc.
(EBIO)
1,390,712
-42%
1,042,000
$2.74
$2,859,352.50
SELL
16 Feb 2016
MCCABE JOHN J
Senior Vice President, Finance, Officer
Eleven Biotherapeutics, Inc.
(EBIO)
8,499
-15%
1,501
$0.27
$405.27
Home